Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Hepatitis B Vaccine Challenge Dose 20 Years Post-Primary Vaccination
NCT00657657Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2008
- Primary completion
- Aug 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Apr 2008; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00657657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657657.